Naproxen Sodium generic
naproxen sodium is an anti-inflammatory drug owned by Bionpharma Inc. The active ingredient in this medication is naproxen sodium. It was first authorized for market use on 17th February, 2006. Currently, naproxen sodium is available in capsule;oral dosage forms. This drug holds a total of 5 patents, none of which have expired yet.
When will Naproxen Sodium generic be available?
The generics of Naproxen Sodium are predicted to be available after 3rd March, 2026. This date is determined by the expiration of the last patent, related to Liquid dosage forms of sodium naproxen.
Naproxen Sodium uses
naproxen sodium is primarily used for the temporary relief of minor aches and pains as well as for the temporary reduction of fever. The active ingredient, naproxen sodium, works by inhibiting the body's production of substances that cause inflammation. This helps to reduce swelling, pain, or fever.
Naproxen Sodium patent expiration
Naproxen Sodium has 5 patents that pertain to its formulation and usage. The last patent, focusing on Liquid dosage forms of sodium naproxen, will expire on 3rd March, 2026. Once this patent expires, the production of Naproxen Sodium generics can commence. Below are the details of the patent: